NCT01223079View on ClinicalTrials.gov

Use of r-hLH (Luveris) in Donors Previously Treated With r-hFSH (Gonal F)

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2008

Conditions
Outcome During r-hFSH StimulationOutcome During r-hFSH and r-hLH Stimulation
Interventions
DRUG

r-hFSH

r-hFSH dose to be determined by the patient's primary doctor and adjusted according to their response

DRUG

r-hFSH and r-hLH

Patients will begin r-hLH at 300IU/day when there are 2 follicles greater than or equal to 14mm.

Trial Locations (1)

07960

Reproductive Medicine Assoicates of New Jersey, Morristown

All Listed Sponsors
lead

Reproductive Medicine Associates of New Jersey

OTHER

NCT01223079 - Use of r-hLH (Luveris) in Donors Previously Treated With r-hFSH (Gonal F) | Biotech Hunter | Biotech Hunter